SEMA4D and B-cell non-Hodgkin lymphoma: However, SEMA4D is rare in B-cell non-Hodgkin's lymphomas, suggesting that its loss might lead to decreased cell adhesion, increased mobility and metastatic potential (Dorfman et al, 1998).